ICU ventilation Devices market Size, Share, Industry, Forecast and outlook (2024-2031)

Market Overview

Global ICU Ventilation Devices Market reached US$ XX billion in 2022 and is expected to reach US$ XX billion by 2030, growing with a CAGR of XX% during the forecast period 2023-2030.

The global ICU ventilation devices market has witnessed significant growth and transformations over the years, with various factors influencing its dynamics such as increasing adoption, rising clinical trials and research activities, and others. Government investments in the development of the devices will continue to drive and boost the global market. These are vital devices that are used in intensive care units, that helps the lungs to work. They are mainly considered lifesaving machines.

There are two types of ICU ventilation devices such as positive-pressure ventilation and negative-pressure ventilation.  The positive-pressure ventilation devices are expected to hold the largest market share over the forecast period. Similarly, North America dominates the ICU ventilation devices market, capturing the largest market share owing to the increasing adoption and presence of major players. 

Owing to the increasing adoption of ICU ventilation devices, rising awareness about the devices, increasing prevalence of severe respiratory diseases, and technological advancements in ventilators are the major factors expected to drive the global ICU ventilation devices market over the forecast period.

Market Scope

Market Dynamics

Increasing Adoption of Advanced Ventilation Devices in ICUs is Expected to Drive the Growth of the Market

The increasing adoption of advanced ventilators in the ICUs is expected to drive the growth of the market over the forecast period. Advanced ventilators offer precise control of respiratory parameters, which can lead to better patient outcomes. They allow for tailored ventilation strategies, reducing the risk of ventilator-induced lung injury and improving overall patient comfort by offering the safety.

For instance, on June 16, 2023, Noccarc, a Pune-based medical technology company proudly unveiled its groundbreaking Noccarc V730i Smart ICU Ventilator, introducing a new era of intelligence to critical care. This state-of-the-art ICU ventilator represents a significant leap forward in patient care, connectivity, and safety, poised to transform intensive care units (ICUs) worldwide. The Noccarc V730i sets new industry standards and marks a remarkable advancement in critical care technology.

Moreover, the ongoing advancements in ICU ventilator technology, including the development of intelligent ventilation solutions, have made these devices more user-friendly, efficient, and capable of adapting to individual patient needs. These advanced ventilator devices offers portability, cost-effectiveness, and other benefits to many patients by reducing the complications.

For instance, on March 24, 2022, Aerobiosys Innovations Pvt. Ltd., a Hyderabad-based startup announced the launch of a smart ventilation system named Jeevan Lite. The smart ventilation system is portable, cost-effective, IoT-based ICU ventilation, and powered by lithium-ion batteries. It operates uninterrupted in SIMV, CMV, Adaptive, and Hybrid modes of ventilation for five hours and is both invasive and non-invasive, with a smartphone app to control the device.

Rising FDA Approvals is Also Expected to Drive the Growth of the Market

The rising FDA approvals are also expected to drive the growth of the market over the forecast period. The increasing FDA approvals for new ICU ventilators can improve the patient's trust in the ventilators. The FDA approvals of different types of ventilators such as invasive, non-invasive, and others helps many patients for enhanced breathing support.

For instance, on July 10, 2023, Getinge, a leading medtech company secured approval from the US Food and Drug Administration (FDA) for its new mechanical ventilator, Servo-air Lite. The company has developed a new turbine-driven ventilator for non-invasive ventilation. The new ventilator provides ICU-level ventilation just like all other Servo ventilators and is aimed at spontaneously breathing patients who require enhanced breathing support.

Additionally, the FDA approvals for new product launches helps to offer quick and efficient results. For instance, on July 12, 2023, Drager received 510(k) clearance from the US FDA for its Evita V600, V800, and Babylog VN800, ventilators. The Evita V800 and Evita 600 combine high-performance ventilation with an aesthetic design enabling quick and efficient operation from the first onset of lung protective ventilation to the integration of a patient care-centered intensive care workplace. 

Moreover, the Drager Babylog VN800 comes with a new user interface and design, which makes it easier and safer for clinicians to operate. The neonatal ventilator supports lung and brain protective ventilation modes throughout the whole respiratory cycle. It facilitates a smooth and seamless transition from O2 therapy to non-invasive ventilation to invasive ventilation and vice versa. 

Risks Associated with the ICU Ventilators is Expected to Hamper the Market's Growth

There are major risks associated with ICU ventilators, which are expected to hamper the market growth over the forecast period. In some patients, the ventilators may cause bacterial infections, lung damage, collapsed lung, heart and blood flow changes, and others. The tube in the airways can bring bacteria into the lungs, causing infections like ventilator-associated pneumonia (VAP). Moreover, the pressure from the ventilator can damage the lungs.

Further, ICU ventilators are complex medical devices, and like any technology, they can malfunction or have some technical issues. Device-related complications can put patients at risk and may lead to many adverse events. The placement of endotracheal tubes or other airway management devices can cause trauma or damage to a patient's airway, this is further expected to increase the risk of complications.

Segment Analysis

The global ICU ventilation devices market is segmented based on type, mode, end-user and region.

The Positive-Pressure Ventilation Segment Accounted for Approximately 39.4% of the ICU Ventilation Devices Market Share

The positive-pressure ventilation segment is expected to hold the largest market share over the forecast period. Positive pressure ventilation includes the process of either using a mask or, more commonly, a ventilator to deliver breaths and to decrease the work of breathing in a critically ill patient. 

Moreover, positive pressure ventilation is delivered in two forms, they are non-invasive positive pressure ventilation (either through a mask) or invasive positive pressure ventilation, which requires delivering breaths either through an endotracheal tube or a tracheostomy tube. These positive-pressure ICU ventilation devices are especially used for respiratory-related patients. They mainly offers a non-invasive nature with more flexibility. 

For instance, on April 8, 2023, Compal Electronics, a Taiwanese electronics company, announced its expansion into the development of innovative therapeutic medical devices. Compal has launched a Bilevel ventilator for chronic obstructive pulmonary disease and respiratory insufficiency caused by central and/or mixed apneas. 

Additionally, the BreathePal Bilevel ventilator provides continuous or intermittent positive pressure ventilation for adults with respiratory insufficiency or failure, suitable for use in hospital ICU settings. With an interchangeable battery and humidifier design, it can be used more easily and with more flexibility.

Geographical Penetration

North America Accounted for Approximately 38.9% of the Market Share, Owing to the Strong Presence of Major Players and Increasing Adoption

North America region is expected to hold the largest market share over the forecast period owing to the strong presence of major players and increasing adoption of ventilators in ICUs. North America is very well-known for its strong presence of major players, these major players mainly focus on the development of advanced ICU ventilators by testing their safety and efficacy. The development of these advanced ventilators offers invasive and non-invasive options and can be cost-effective.

For instance, on October 11, 2021, Movair, a respiratory therapy company formerly known as International Biophysics Corporation, announced the U.S. commercial launch of Luisa, an advanced ventilator intended for use in institutions, hospital ICUs, or portable applications for both invasive and non-invasive ventilation. Luisa can be used through the FDA's Emergency Use Authorization in response to the increasing need for safe and effective ventilators. 

Furthermore, North America is also known for the increasing adoption of ICU ventilators. The region has a high respiratory-related patient population, so there is a continuously increasing demand for ICU ventilators in the region, leading to market dominance in the region.

Competitive Landscape

The major global players in the ICU ventilation devices market include Koninklijke Philips N.V., Medtronic Plc, ALLIED HEALTHCARE PRODUCTS, INC., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Drägerwerk AG & Co. KGaA, ResMed Inc., Nihon Kohden Corporation, VYAIRE MEDICAL, INC., Metran Co., Ltd., and Heyer Medical AG, among others. 

COVID-19 Impact Analysis

The outbreak of the COVID-19 pandemic in late 2019 created a positive impact on the ICU ventilators market worldwide. COVID-19 has become one of the leading causes of death worldwide. According to the NIH, it is estimated that 15–20% of cases require hospitalization and 3–5% require critical care. While experience with COVID-19 continues to grow, it has been reported that mortality rates range from 50–97% in those requiring mechanical ventilation in ICU. 

Moreover, the onset of the pandemic in early 2020 led to widespread lockdowns and restrictions, due to increased covid cases and complications, there is a continuous and increased demand for ventilators for intensive care. Due to the increased adoption, many hospitals faced shortages of ventilators, so novel advancements such as AI in ventilators have increased the demand for the market in 2020.

For instance, on August 18, 2020, at a time when ventilators have become critical for treating severe coronavirus cases, an India-Dutch start-up mentored by Hyderabad Security Cluster developed smart ventilators that are integrated with artificial intelligence (AI) and machine learning (ML). LEVEN Medical has come up with three models of ventilators such as SMART Ventilator, C5 Covid-19 Ventilator, and ICU Ventilator. 

However, the COVID-19 pandemic severely disrupted global supply chains, impacting the transportation of ventilators. Movement restrictions and border closures delayed shipments and caused ventilator transportation delays. Additionally, many countries faced shortages of ICU ventilators for treatment due to disruptions in their supply chain networks.

Key Developments

• On December 13, 2022, Saudi Arabia launched the first locally manufactured intensive-care ventilator. The new product was developed through a partnership between Medtronic Saudi Arabia, a leading global health technology company, and Al-Rowad Technical Systems Company. The partnership between the two companies would contribute to manufacturing 1,200 intensive-care ventilators annually, with an average Saudization of 46 percent of the employees within the first two years. The partnership also aims to work for the local manufacturing of advanced generation of ventilators for use in intensive care units and critical care units.
• On May 18, 2021, CorVent Medical, a private medtech company focused on developing versatile, lifesaving ventilators for critical care, received CE Mark approval and is ready to launch commercial use of its RESPOND-19 Ventilator in Europe. The novel system is designed for easy-to-use, flexible expansion of critical care ventilation capacity to allow hospitals to improve the treatment of critically ill patients suffering from acute respiratory distress syndrome (ARDS). Optimized for day-to-day clinical use and overflow ventilation needs, the system provides invasive and non-invasive respiratory support at a lower cost of ownership without the traditional requirements for costly service or maintenance plans.

DataM Intelligence Opinion:

According to the DataM Intelligence, the ICU ventilation devices market experiencing the rapid growth in recent years and is expected to grow rapidly in the coming years due to its increasing adoption and increasing regulatory approvals for better patient outcomes. The development of technologically advanced ventilators is a key market trend. However, the risks associated with the ventilators are expected to hamper the market growth over the forecast period.

Moreover, many clinical trials and research activities are still going on for the development of advanced ventilators with positive outcomes, which is expected to the growth of the global ICU ventilation devices market in the upcoming years.

Why Purchase the Report?

• To visualize the global ICU ventilation devices market segmentation based on type, mode, end-user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development. 
• Excel data sheet with numerous data points of ICU ventilation devices market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The global ICU ventilation devices market report would provide approximately 61 tables, 58 figures, and 186 Pages.

Target Audience 2023

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

Suggestions for Related Report

• Global Mechanical Ventilator Market
• Global Energy Recovery Ventilator Market
• Vietnam and Philippines Mechanical Ventilator Market

For more medical devices related reports, please click here